DGAP-PVR: RHÖN-KLINIKUM AG: Release according to Article

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
DGAP-PVR: RHÖN-KLINIKUM AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

RHÖN-KLINIKUM AG 12.06.2014 09:00 Dissemination of a Voting Rights Announcement, transmitted by DGAP - a company of EQS Group AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- Notification according to section 26 para. 1 WpHG Credit Suisse Group AG, Zürich, Switzerland, Credit Suisse AG, Zürich, Switzerland, Credit Suisse Investments (UK), London, Great Britain, Credit Suisse Investment Holdings (UK), London, Great Britain and Credit Suisse Securities (Europe) Limited, London, Great Britain notified us on 10 and 11 June 2014 pursuant to section 25a para. 1 WpHG of the following: 1) On 5 June 2014, Credit Suisse Group AG exceeded the threshold of 5% of the voting rights of RHÖN-KLINIKUM AG, Salzburger Leite 1, 97616 Bad Neustadt a. d. Saale, Germany. On that date, Credit Suisse Group AG held 6.00% of the voting rights in RHÖN-KLINIKUM AG (equals 8,298,560 voting rights). From these voting rights a proportion of 1.59% (equals 2,199,011 voting rights) is based on voting rights pursuant to sections 21, 22 WpHG. In addition, a proportion of 3.02% (equals 4,181,022 voting rights) is based on (financial/other) instruments pursuant to section 25 WpHG. From the voting rights based on instruments pursuant to section 25 WpHG a proportion of 3.02% (equals 4,181,022 voting rights) is held indirectly. In addition, a proportion of 1.39% (equals 1,918,527 voting rights) is based on (financial/other) instruments pursuant to section 25a WpHG. From the voting rights based on instruments pursuant to section 25a WpHG a proportion of 1.39% (equals 1,918,527 voting rights) is held indirectly. Chain of controlled undertakings: Credit Suisse AG, Credit Suisse International, Credit Suisse Investments (UK), Credit Suisse Investment Holdings (UK), Credit Suisse Securities (Europe) Limited. The (financial/other) instruments pursuant to section 25a WpHG are described as follows: - Equity Swap, cash settlement (expiration date: 20 June 2014) - Equity Swap, cash settlement (expiration date: 23 June 2014) - Equity Swap, cash settlement (expiration date: 4 November 2014) - Equity Swap, cash settlement (expiration date: 12 January 2015) - Equity Swap, cash settlement (expiration date: 27 January 2015) - Equity Swap, cash settlement (expiration date: 18 June 2015) - Equity Swap, cash settlement (expiration date: 3 July 2015) - Equity Swap, cash settlement (expiration date: 15 December 2015) 2) On 5 June 2014, Credit Suisse AG exceeded the threshold of 5% of the voting rights of RHÖN-KLINIKUM AG, Salzburger Leite 1, 97616 Bad Neustadt a. d. Saale, Germany. On that date Credit Suisse AG held 6.00% of the voting rights in RHÖN-KLINIKUM AG (equals 8,298,560 voting rights). From these voting rights a proportion of 1.59% (equals 2,199,011 voting rights) is based on voting rights pursuant to sections 21, 22 WpHG. In addition, a proportion of 3.02% (equals 4,181,022 voting rights) is based on (financial/other) instruments pursuant to section 25 WpHG. From the voting rights based on instruments pursuant to section 25 WpHG a proportion of 2.82% (equals 3,899,022 voting rights) is held indirectly. In addition, a proportion of 1.39% (equals 1,918,527 voting rights) is based on (financial/other) instruments pursuant to section 25a WpHG. From the voting rights based on instruments pursuant to section 25a WpHG a proportion of 1.39% (equals 1,918,527 voting rights) is held indirectly. Chain of controlled undertakings: Credit Suisse International, Credit Suisse Investments (UK), Credit Suisse Investment Holdings (UK), Credit Suisse Securities (Europe) Limited. The (financial/other) instruments pursuant to section 25a WpHG are described as follows: - Equity Swap, cash settlement (expiration date: 20 June 2014) - Equity Swap, cash settlement (expiration date: 23 June 2014) - Equity Swap, cash settlement (expiration date: 4 November 2014) - Equity Swap, cash settlement (expiration date: 12 January 2015) - Equity Swap, cash settlement (expiration date: 27 January 2015) - Equity Swap, cash settlement (expiration date: 18 June 2015) - Equity Swap, cash settlement (expiration date: 3 July 2015) - Equity Swap, cash settlement (expiration date: 15 December 2015) 3) On 6 June 2014, Credit Suisse Investments (UK) exceeded the threshold of 5% of the voting rights of RHÖN-KLINIKUM AG, Salzburger Leite 1, 97616 Bad Neustadt a. d. Saale, Germany. On that date Credit Suisse AG held 6.02% of the voting rights in RHÖN-KLINIKUM AG (equals 8,327,095 voting rights). From these voting rights a proportion of 2.09% (equals 2,890,061 voting rights) is based on voting rights pursuant to sections 21, 22 WpHG. In addition, a proportion of 2.09% (equals 2,892,398 voting rights) is based on (financial/other) instruments pursuant to section 25 WpHG. From the voting rights based on instruments pursuant to section 25 WpHG a proportion of 2.09% (equals 2,892,398 voting rights) is held indirectly. In addition, a proportion of 1.84% (equals 2,544,636 voting rights) is based on (financial/other) instruments pursuant to section 25a WpHG. From the voting rights based on instruments pursuant to section 25a WpHG a proportion of 1.84% (equals 2,544,636 voting rights) is held indirectly. Chain of controlled undertakings: Credit Suisse Investment Holdings (UK), Credit Suisse Securities (Europe) Limited. The (financial/other) instruments pursuant to section 25a WpHG are described as follows: - Equity Swap, cash settlement (expiration date: 4 November 2014) - Equity Swap, cash settlement (expiration date: 29 December 2014) - Equity Swap, cash settlement (expiration date: 12 January 2015) - Equity Swap, cash settlement (expiration date: 27 January 2015) - Equity Swap, cash settlement (expiration date: 18 June 2015) - Equity Swap, cash settlement (expiration date: 3 July 2015) - Equity Swap, cash settlement (expiration date: 15 December 2015) 4) On 6 June 2014, Credit Suisse Investment Holdings (UK) exceeded the threshold of 5% of the voting rights of RHÖN-KLINIKUM AG, Salzburger Leite 1, 97616 Bad Neustadt a. d. Saale, Germany. On that date Credit Suisse AG held 6.02% of the voting rights in RHÖN-KLINIKUM AG (equals 8,327,095 voting rights). From these voting rights a proportion of 2.09% (equals 2,890,061 voting rights) is based on voting rights pursuant to sections 21, 22 WpHG. In addition, a proportion of 2.09% (equals 2,892,398 voting rights) is based on (financial/other) instruments pursuant to section 25 WpHG. From the voting rights based on instruments pursuant to section 25 WpHG a proportion of 2.09% (equals 2,892,398 voting rights) is held indirectly. In addition, a proportion of 1.84% (equals 2,544,636 voting rights) is based on (financial/other) instruments pursuant to section 25a WpHG. From the voting rights based on instruments pursuant to section 25a WpHG a proportion of 1.84% (equals 2,544,636 voting rights) is held indirectly. Chain of controlled undertakings: Credit Suisse Securities (Europe) Limited. The (financial/other) instruments pursuant to section 25a WpHG are described as follows: - Equity Swap, cash settlement (expiration date: 4 November 2014) - Equity Swap, cash settlement (expiration date: 29 December 2014) - Equity Swap, cash settlement (expiration date: 12 January 2015) - Equity Swap, cash settlement (expiration date: 27 January 2015) - Equity Swap, cash settlement (expiration date: 18 June 2015) - Equity Swap, cash settlement (expiration date: 3 July 2015) - Equity Swap, cash settlement (expiration date: 15 December 2015) 5) On 6 June 2014, Credit Suisse Securities (Europe) Limited exceeded the threshold of 5% of the voting rights of RHÖN-KLINIKUM AG, Salzburger Leite 1, 97616 Bad Neustadt a. d. Saale, Germany. On that date Credit Suisse AG held 6.02% of the voting rights in RHÖN-KLINIKUM AG (equals 8,327,095 voting rights). From these voting rights a proportion of 2.09% (equals 2,890,061 voting rights) is based on voting rights pursuant to sections 21, 22 WpHG. In addition, a proportion of 2.09% (equals 2,892,398 voting rights) is based on (financial/other) instruments pursuant to section 25 WpHG. From the voting rights based on instruments pursuant to section 25 WpHG a proportion of 0% (equals 0 voting rights) is held indirectly. In addition, a proportion of 1.84% (equals 2,544,636 voting rights) is based on (financial/other) instruments pursuant to section 25a WpHG. From the voting rights based on instruments pursuant to section 25a WpHG a proportion of 0% (equals 2,544,636 voting rights) is held indirectly. The (financial/other) instruments pursuant to section 25a WpHG are described as follows: - Equity Swap, cash settlement (expiration date: 4 November 2014) - Equity Swap, cash settlement (expiration date: 29 December 2014) - Equity Swap, cash settlement (expiration date: 12 January 2015) - Equity Swap, cash settlement (expiration date: 27 January 2015) - Equity Swap, cash settlement (expiration date: 18 June 2015) - Equity Swap, cash settlement (expiration date: 3 July 2015) - Equity Swap, cash settlement (expiration date: 15 December 2015) Bad Neustadt a. d. Saale, 12 June 2014 The Board of Management ___________________________________________________________________________ Dr. Kai G. Klinger SVP - Investor Relations and Corporate Finance RHÖN-KLINIKUM AG Schlossplatz 1 97616 Bad Neustadt a. d. Saale Phone: +49 9771 65 - 1318 Fax: +49 9771 99 - 1736 12.06.2014 DGAP's Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------------- Language: English Company: RHÖN-KLINIKUM AG Schlossplatz 1 97616 Bad Neustadt a.d.Saale Germany Internet: www.rhoen-klinikum-ag.com End of Announcement DGAP News-Service ---------------------------------------------------------------------------

Scroll down for more posts ▼

Top 10 Most Recent News Articles

AEVEX Faces Legal Scrutiny Amid Secondary Offering Stir

Updated Category News Views 3

AEVEX on the Legal Hook: What's Going Down? Look, nobody likes bad news, especially when their pockets feel the pinch. AEVEX Corp. (NYSE: AVEX) kicked up quite the dust cloud when their stock plummeted after a secondary offering—dropping a whopping 16% at first glance, and then an extra seven in the blink of an eye. Timing Is Everything in the Stock Game Set the stage:...

Continue Reading
Lincoln's Legal Tangle: Stock Plunge Sparks Lawsuit

Updated Category News Views 0

Lincoln Educational's Troubles Unravel You think you've seen it all, then boom—Lincoln Educational Services hit the skids with their stock diving close to 25% back in August 2026. This ain't your usual small hiccup; we’re talking a lawsuit filed and investors eyeing action as miserly as a broker when the market tumbles. News like this? It shakes the rafters of any...

Continue Reading
Triller's Tangle: Investors Face Massive Stock Drop

Updated Category News Views 0

A Descent into Legal Quagmire Investor action notices usually scream trouble, and this time it’s Triller Group Inc. (NASDAQ: ILLR) taking the brunt. If you haven’t been under a rock, you’ve heard they’re in a spot of bother, courtesy of a gnarly combination of financial mishaps and misleading statements. It’s a classic case of a company shooting itself in the...

Continue Reading
Mastering Power Efficiency with Phase Converters

Updated Category News Views 6

Powering Multiple Machines: A New Approach? You ever look at a workshop crammed with machines and wonder if it's all a waste of space, time, and money? Jay Yuergens from North America Phase Converter Co. gives us the lowdown on how one rotary or digital phase converter can handle the load. And let me tell you, it ain't as crazy as it sounds. It's all about finesse and...

Continue Reading
PG&E Delivers $26M Climate Credit to Small Biz

Updated Category News Views 7

California's Big Move for Small Businesses In a world where every dollar counts, small businesses across Northern and Central California are getting a helping hand. Pacific Gas and Electric Company (PG&E) is stepping up with a tidy little climate credit thanks to the state's Cap-and-Invest Program. Eligible businesses are automatically set to receive a $36.18 credit off...

Continue Reading
Partner Climbs 25 Spots on ENR's Environmental Firm List

Updated Category News Views 0

A Leap Forward in Environmental Expertise Alright, folks, let's dive into some real grit. Partner Engineering and Science, Inc. has pulled off a neat little trick. They've jumped up 25 spots on the 2026 Engineering News-Record's Top 200 Environmental Firms list. They’ve been making this list for 14 years straight, and that's no fluke. It's a hard road, especially when...

Continue Reading
Sophont's Holon-S1: Revolutionizing Pathology and AI

Updated Category News Views 3

Pushing Boundaries in Tumor Analysis with AI In the world of medical AI, it's not every day you hear about a tool that claims to read the secrets hidden within routine pathology slides to predict tumor behavior. Yet, here we are with Sophont's latest brainchild, the Holon-S1. This thing is more than just another AI model; it's a giant leap towards pulling the veil off...

Continue Reading
Hyliion Legal Woes Shake Investor Confidence

Updated Category News Views 5

Legal Storm Brews Over Hyliion Investments If you think riding the stock market is like sailing a calm sea, wake up. Hyliion Holdings Corp. (NYSE:HYLN) finds itself steaming headlong into rough waters. A securities class action lawsuit, Olmeta v. Hyliion Holdings Corp., accuses the company of embellishing its ambitions. The lawsuit cites potential wrongdoing in a...

Continue Reading
XTI Aerospace Eyes Growth Amid Revenue Slip

Updated Category News Views 0

A Second Quarter Snapshot Ah, the world of aerospace—where soaring ambitions often face a reality check. XTI Aerospace, hitching a ride on the drone tech boom, found itself dealing with a mixed bag this past second quarter. Coming from the streets of Miami with its quarterly numbers, XTI's interim CEO Jeremy Schneiderman is banking on drones to lift their revenue skies....

Continue Reading
JELD-WEN Schedules Q3 2026 Earnings Call Amid Global Reach

Updated Category News Views 0

Looking Ahead: JELD-WEN's Q3 Results Exploration Alright folks, buckle up. JELD-WEN Holding, Inc., the name any DIY'er worth their salt recognizes for doors and windows, has set the stage for unveiling its third quarter 2026 performance. They've earmarked November 3 post-market for us to comb through the numbers, and they're wasting no time by getting on a conference call...

Continue Reading

Top 5 Most Recently Viewed Articles

MannKind Corporation's Impressive Growth in First Quarter 2025

Updated Category News Views 417

MannKind Corporation's Financial Results Overview MannKind Corporation (NASDAQ: MNKD) has made a significant impact in the first quarter of 2025, reporting robust financial results that reflect the company’s ongoing progress and commitment to innovation. With reported revenues reaching $78 million, an 18% increase compared to the previous year, MannKind is clearly on a...

Continue Reading
Global Dialogue on Sustainable Development Held in Major City

Updated Category News Views 88

Global Symposium on Sustainable Development Recently, a significant event entitled the International Symposium on Sustainable Development took place, organized by advisors and institutions devoted to environmental issues. The symposium aimed to foster a global platform for high-level dialogue surrounding important themes regarding humans' relationship with nature,...

Continue Reading
Unraveling Trump's $2 Trillion Strategy for Tech Dominance

Updated Category News Views 286

Understanding Trump's $2 Trillion Strategy Former CIA officer Buck Sexton has recently shed light on what he describes as "Manhattan 2," an ambitious initiative by President Trump to restore American leadership in the global technology landscape. According to Sexton, this plan could mobilize nearly $2 trillion to engage in a fierce competition against other nations,...

Continue Reading
Ipsen Reports Share Capital and Voting Rights Information

Updated Category News Views 131

Key Information on Ipsen's Share Capital and Voting Rights In the world of corporate governance, transparency regarding voting rights and share capital is paramount. Ipsen, a leader in biopharmaceuticals, diligently provides this crucial information, ensuring stakeholders remain informed about the voting power associated with their shares. Understanding Share Capital...

Continue Reading
EPIC Expands Life Insurance Solutions with Strategic Acquisition

Updated Category News Views 85

EPIC Insurance Brokers made headlines back when it snagged TDC Life, a big player in the life insurance game, back in 2024. This move wasn’t just another notch on the belt; it was a calculated gamble to solidify EPIC’s grip on the life insurance sector. With TDC under the Vanbridge Life & Executive Benefits umbrella, traders started wondering how this would impact...

Continue Reading